PL3003411T4 - Degradowalna kompozycja hemostatyczna - Google Patents

Degradowalna kompozycja hemostatyczna

Info

Publication number
PL3003411T4
PL3003411T4 PL14736422T PL14736422T PL3003411T4 PL 3003411 T4 PL3003411 T4 PL 3003411T4 PL 14736422 T PL14736422 T PL 14736422T PL 14736422 T PL14736422 T PL 14736422T PL 3003411 T4 PL3003411 T4 PL 3003411T4
Authority
PL
Poland
Prior art keywords
haemostat composition
degradable
degradable haemostat
composition
haemostat
Prior art date
Application number
PL14736422T
Other languages
English (en)
Other versions
PL3003411T3 (pl
Inventor
Craig Hardy
Andrew HOGGARTH
June Gladman
Original Assignee
Medtrade Products Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtrade Products Limited filed Critical Medtrade Products Limited
Publication of PL3003411T4 publication Critical patent/PL3003411T4/pl
Publication of PL3003411T3 publication Critical patent/PL3003411T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0042—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dispersion Chemistry (AREA)
  • Composite Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Biological Depolymerization Polymers (AREA)
PL14736422T 2013-05-30 2014-05-28 Degradowalna kompozycja hemostatyczna PL3003411T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1309674.8A GB2514592A (en) 2013-05-30 2013-05-30 Degradable haemostat composition
EP14736422.8A EP3003411B1 (en) 2013-05-30 2014-05-28 Degradable haemostat composition
PCT/GB2014/051624 WO2014191738A1 (en) 2013-05-30 2014-05-28 Degradable haemostat composition

Publications (2)

Publication Number Publication Date
PL3003411T4 true PL3003411T4 (pl) 2022-01-24
PL3003411T3 PL3003411T3 (pl) 2022-01-24

Family

ID=48805490

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14736422T PL3003411T3 (pl) 2013-05-30 2014-05-28 Degradowalna kompozycja hemostatyczna

Country Status (16)

Country Link
US (3) US10933160B2 (pl)
EP (1) EP3003411B1 (pl)
JP (1) JP6608808B2 (pl)
KR (1) KR102324247B1 (pl)
CN (2) CN105431176A (pl)
AU (1) AU2014272868C1 (pl)
BR (1) BR112015029956B1 (pl)
CA (1) CA2913658C (pl)
DK (1) DK3003411T3 (pl)
ES (1) ES2897623T3 (pl)
GB (1) GB2514592A (pl)
MX (1) MX2015016387A (pl)
PL (1) PL3003411T3 (pl)
PT (1) PT3003411T (pl)
RU (1) RU2682717C2 (pl)
WO (1) WO2014191738A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016178829A1 (en) * 2015-05-06 2016-11-10 Gyrus Acmi, Inc. (D.B.A. Olympus Surgical Technologies America) Carboxymethyl chitosan sponge formulation
RU2635465C1 (ru) * 2016-08-10 2017-11-13 Александр Евгеньевич Федотов Гемостатический материал, гемостатическое средство и перевязочный материал на его основе
TR201714879A2 (tr) * 2017-10-03 2019-04-22 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Hemostati̇k kompozi̇syonlar
WO2019133931A1 (en) 2017-12-29 2019-07-04 Tricol Biomedical, Inc. Delivery systems for control of bleeding in transurethral prostatectomy
JP2021508751A (ja) * 2017-12-29 2021-03-11 トリコル バイオメディカル， インコーポレイテッド 溶解に耐える組織接着性キトサン材料
US20210052766A1 (en) * 2017-12-29 2021-02-25 Tricol Biomedical, Inc. Chitosan dressing for control of gastrointestinal bleeding
US20210059868A1 (en) * 2017-12-29 2021-03-04 Tricol Biomedical, Inc. Chitosan dressing for control of bleeding in transurethral prostatectomy
US11564673B2 (en) 2017-12-29 2023-01-31 Tricol Biomedical, Inc. Delivery systems for control of gastrointestinal bleeding
EP3737432B1 (en) 2018-01-12 2022-12-28 Boston Scientific Scimed Inc. Powder for achieving hemostasis
CN109432481A (zh) * 2018-12-06 2019-03-08 广州润虹医药科技股份有限公司 一种止血抗菌的聚氨酯敷料及其制备方法
CN118079064A (zh) 2019-12-26 2024-05-28 工匠实验室株式会社 局部止血材料的制造方法以及局部止血材料
CN111714689B (zh) * 2020-07-09 2022-04-22 石家庄亿生堂医用品有限公司 一种壳聚糖止血粉及其制备方法
CN114748676B (zh) * 2022-04-08 2022-11-18 四川大学 一种具有Janus结构的壳聚糖基高效止血剂、其制备方法及应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394373A (en) * 1981-04-06 1983-07-19 Malette William Graham Method of achieving hemostasis
JPS624232A (ja) * 1985-07-01 1987-01-10 Unitika Ltd 止血剤
US5064653A (en) * 1988-03-29 1991-11-12 Ferris Mfg. Co. Hydrophilic foam compositions
US5169535A (en) 1989-09-22 1992-12-08 Kurita Water Industries Ltd. Method of removing endotoxin
JP3569927B2 (ja) * 1993-03-15 2004-09-29 栗田工業株式会社 エンドトキシンの除去方法
US5578661A (en) * 1994-03-31 1996-11-26 Nepera, Inc. Gel forming system for use as wound dressings
ATE549996T1 (de) * 2001-06-14 2012-04-15 Gregory Kenton W Verfahren zur herstellung von chitosan- wundauflagen
CA2471994A1 (en) * 2001-12-31 2003-07-17 Ares Laboratories, Llc Hemostatic compositions and methods for controlling bleeding
US8269058B2 (en) * 2002-06-14 2012-09-18 Hemcon Medical Technologies, Inc. Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan
US7125967B2 (en) 2003-10-08 2006-10-24 Adjuvant Pharmaceuticals, Llc Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
JP2005145873A (ja) * 2003-11-14 2005-06-09 Kyoko Koto ペプチド及びタンパク性薬物放出制御剤の調製方法及びその薬物放出制御剤
AU2005216094B2 (en) * 2004-02-23 2010-12-23 Loma Linda University Medical Center Hemostatic agent for topical and internal use
US20050203058A1 (en) * 2004-03-11 2005-09-15 Johnson Edwin L. Compositions of alpha- and beta-chitosan and methods of preparing them
CN1833732A (zh) 2005-03-17 2006-09-20 李毅彬 一种抗菌医用敷料的制造方法及其用途
SI1917218T1 (sl) 2005-06-14 2017-12-29 Genis Hf. Sestavki delno deacetiliranih hitinskih derivatov
CA2614750A1 (en) * 2005-07-13 2007-01-18 Hemcon, Inc. Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as chitosan
CN101309709A (zh) * 2005-09-21 2008-11-19 苏尔莫迪克斯公司 包含天然生物可降解的多糖的涂层和物品
GB0526503D0 (en) * 2005-12-29 2006-02-08 Medtrade Products Ltd Hemostatic material
US20080248508A1 (en) 2006-08-17 2008-10-09 Shenda Baker Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials
WO2008063503A2 (en) * 2006-11-13 2008-05-29 Hawaii Chitopure, Inc. Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials.
US8932560B2 (en) * 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
CN101081308A (zh) * 2007-05-14 2007-12-05 罗晓浔 壳聚糖止血剂
CN101053669B (zh) * 2007-05-22 2010-05-26 中国海洋大学 一种水溶性壳聚糖基止血愈创海绵及其制备方法和应用
EP2173293A1 (en) * 2007-07-16 2010-04-14 Hemcon Medical Technologies, Inc. Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chistosan
CZ2007716A3 (cs) * 2007-10-15 2009-04-29 Elmarco S. R. O. Zpusob výroby nanovláken
WO2009056602A1 (en) * 2007-10-30 2009-05-07 Viscogel Ab Chitosan composition
GB2461019B (en) 2008-04-25 2013-06-05 Medtrade Products Ltd Haemostatic material
GB2463523B (en) * 2008-09-17 2013-05-01 Medtrade Products Ltd Wound care device
US20100100123A1 (en) * 2008-10-17 2010-04-22 Confluent Surgical, Inc. Hemostatic implant
WO2010107794A2 (en) 2009-03-16 2010-09-23 University Of Memphis Research Foundation Compositions and methods for delivering an agent to a wound
CN101601643A (zh) * 2009-06-30 2009-12-16 复旦大学附属中山医院 一种骨骼止血凝胶
IN2012DN00445A (pl) * 2009-07-14 2015-05-15 Tufts College
RU2468129C2 (ru) * 2010-12-30 2012-11-27 Государственное образовательное учреждение высшего профессионального образования "Саратовский государственный университет им. Н.Г. Чернышевского" Биополимерное волокно, состав формовочного раствора для его получения, способ приготовления формовочного раствора, полотно биомедицинского назначения, способ его модификации, биологическая повязка и способ лечения ран
GB201104175D0 (en) 2011-03-11 2011-04-27 Medtrade Products Ltd Haemostatic material
GB201205174D0 (en) * 2012-03-23 2012-05-09 Medtrade Products Ltd Process for producing low endotoxin chitosan
CN103100107B (zh) * 2013-01-25 2014-08-20 安吉县阳光医药用品有限责任公司 一种几丁质医用生物敷料的制备方法

Also Published As

Publication number Publication date
CA2913658A1 (en) 2014-12-04
KR102324247B1 (ko) 2021-11-08
DK3003411T3 (da) 2021-09-20
CN114949334A (zh) 2022-08-30
WO2014191738A8 (en) 2015-12-23
US20170258959A1 (en) 2017-09-14
CA2913658C (en) 2022-08-02
PT3003411T (pt) 2021-09-22
PL3003411T3 (pl) 2022-01-24
EP3003411B1 (en) 2021-06-16
KR20160033661A (ko) 2016-03-28
MX2015016387A (es) 2016-10-14
GB201309674D0 (en) 2013-07-17
US20160106882A1 (en) 2016-04-21
JP6608808B2 (ja) 2019-11-20
ES2897623T3 (es) 2022-03-02
US10933160B2 (en) 2021-03-02
AU2014272868C1 (en) 2018-09-06
AU2014272868A1 (en) 2016-01-21
GB2514592A (en) 2014-12-03
RU2015155733A (ru) 2017-07-06
CN105431176A (zh) 2016-03-23
RU2682717C2 (ru) 2019-03-21
BR112015029956B1 (pt) 2020-11-03
JP2016522208A (ja) 2016-07-28
EP3003411A1 (en) 2016-04-13
US20170258958A1 (en) 2017-09-14
BR112015029956A2 (pt) 2017-07-25
AU2014272868B2 (en) 2018-03-08
WO2014191738A1 (en) 2014-12-04

Similar Documents

Publication Publication Date Title
PL3065569T3 (pl) Kompozycja
PL3003411T4 (pl) Degradowalna kompozycja hemostatyczna
EP2889350A4 (en) ADHESIVE COMPOSITION
PT3003412T (pt) Composição hemostática degradável
PT3027750T (pt) Composição biocatalítica
EP3006525A4 (en) ASPHALT-URETHANE COMPOSITION
HK1214088A1 (zh) 油脂組合物
GB201319540D0 (en) Composition
GB201318489D0 (en) Composition
GB201317388D0 (en) Composition
GB201320919D0 (en) Composition
GB201306984D0 (en) Composition
EP3066178A4 (en) GREASE COMPOSITION
GB201322772D0 (en) Composition
GB201320303D0 (en) Composition
GB201319538D0 (en) Composition
GB201317196D0 (en) Composition
GB201307622D0 (en) Composition
GB201420672D0 (en) Composition
EP2977420A4 (en) ADHESIVE COMPOSITION
GB201308502D0 (en) Composition
GB201301774D0 (en) Composition
GB201318394D0 (en) Composition
GB201320675D0 (en) Composition
GB201305622D0 (en) Composition